Dextranomer and Hyaluronate Derivatives (Deflux) and Tafenoquine Succinate (Arakoda)
Determining the interaction of Dextranomer and Hyaluronate Derivatives (Deflux) and Tafenoquine Succinate (Arakoda) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dextranomer / sodium hyaluronate
Brand name: Solesta
Synonyms: Dextranomer and sodium hyaluronate
Generic Name: tafenoquine
Brand name: Arakoda, Krintafel
Synonyms: Tafenoquine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dextranomer and Hyaluronate Derivatives (Deflux)-Tafenoquine Succinate (Krintafel)
- Dextranomer and Hyaluronate Derivatives (Deflux)-Tafinlar
- Dextranomer and Hyaluronate Derivatives (Deflux)-Tafluprost
- Dextranomer and Hyaluronate Derivatives (Deflux)-Tafluprost ophthalmic
- Dextranomer and Hyaluronate Derivatives (Deflux)-Tagamet
- Dextranomer and Hyaluronate Derivatives (Deflux)-Tagamet HB
- Tafenoquine Succinate (Arakoda)-Dextranomer and Hyaluronate Derivatives (Solesta)
- Tafenoquine Succinate (Arakoda)-Dextranomer and sodium hyaluronate
- Tafenoquine Succinate (Arakoda)-Dextroamphetamine
- Tafenoquine Succinate (Arakoda)-Dextroamphetamine and amphetamine
- Tafenoquine Succinate (Arakoda)-Dextroamphetamine and Amphetamine Extended-Release Capsules (Adderall XR)
- Tafenoquine Succinate (Arakoda)-Dextroamphetamine and Amphetamine Extended-Release Capsules (Mydayis)